Explaining the latest research in Alzheimer's disease and other dementias.
September 12, 2023
More people are affected by dementia than ever — yet each person's individual risk is actually falling, and by a surprising amount. Here's what the data shows, and why.
Read article →
September 9, 2023
Lecanemab is the first genuinely new Alzheimer's drug in 25 years. Who is it for, how well does it actually work, and what are the risks? A clear-eyed look at the evidence.
Read article →
September 8, 2023
A plain-language primer on what 'dementia' really means, how it's diagnosed, the main types, and how research moves from the lab toward a cure.
Read article →